[At present, PEG-IFN-alpha plus ribavirin should be the treatment of choice in patients with dominant HCV replication.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations inferred from text-mining the literature.
DisGeNET evidence - LITERATURE